CN111378768A - 一种检测百日咳杆菌的试剂盒 - Google Patents
一种检测百日咳杆菌的试剂盒 Download PDFInfo
- Publication number
- CN111378768A CN111378768A CN201811643101.5A CN201811643101A CN111378768A CN 111378768 A CN111378768 A CN 111378768A CN 201811643101 A CN201811643101 A CN 201811643101A CN 111378768 A CN111378768 A CN 111378768A
- Authority
- CN
- China
- Prior art keywords
- bordetella pertussis
- lamp
- reaction
- amplification
- detection method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000588832 Bordetella pertussis Species 0.000 title claims abstract description 38
- 238000001514 detection method Methods 0.000 claims abstract description 33
- 238000006243 chemical reaction Methods 0.000 claims abstract description 20
- 230000003321 amplification Effects 0.000 claims abstract description 18
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 18
- 108020004707 nucleic acids Proteins 0.000 claims description 16
- 150000007523 nucleic acids Chemical class 0.000 claims description 16
- 102000039446 nucleic acids Human genes 0.000 claims description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 7
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 5
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 4
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 4
- 229960003237 betaine Drugs 0.000 claims description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 238000012360 testing method Methods 0.000 claims description 4
- 239000011324 bead Substances 0.000 claims description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 2
- 108091036078 conserved sequence Proteins 0.000 abstract description 4
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 238000007397 LAMP assay Methods 0.000 description 40
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 238000013461 design Methods 0.000 description 4
- 238000011901 isothermal amplification Methods 0.000 description 4
- 201000005702 Pertussis Diseases 0.000 description 3
- 238000003771 laboratory diagnosis Methods 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 241000588807 Bordetella Species 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公开了百日咳杆菌的基于LAMP技术的检测试剂盒。LAMP引物根据百日咳杆菌的特异保守序列设计,每组引物包含4条寡核苷酸,通过LAMP反应体系利用恒温扩增仪对百日咳杆菌进行荧光鉴定检测。本发明为百日咳杆菌测提供了一个新的技术平台,适宜在基层单位、现场监测和床旁检测中推广应用。
Description
技术领域
本发明属于以等温扩增为代表的分子生物学检测方法在百日咳杆菌检测方面的应用,即百日咳杆菌的环介导等温扩增检测方法和试剂盒。
背景技术
百日咳杆菌(Bordetella pertussis)为卵圆形短小杆菌,大小为0.5~1.5×0.2~0.5um,属鲍特氏菌属Bordetella,无鞭毛、芽胞。百日咳杆菌主要经飞沫传播,可引起人类百日咳,易感儿童接触病人后发病率接近90%,一岁以下患儿病死率高。百日咳潜伏期1~2周。发病早期(卡他期)仅有轻度咳嗽。细菌此时在气管和支气管粘膜上大量繁殖并随飞沫排出,传染性最大,且该病病程较长,故名百日咳。百日咳杆菌以分离培养为主,标本采用鼻咽试子或咳皿法,根据菌落形态,涂片染色镜检作出初步诊断。确诊可用分离菌与Ⅰ相免疫血清作血清玻片凝集或免疫荧光染色。
近年来,分子生物学方法不断被应用到呼吸道病原体的快速检测中,呼吸道病原体的实验室诊断方法取得了很大的进展,核酸检测已经成为了呼吸道病原体实验室诊断的发展方向。相对于传统的实验室检测法,分子诊断技术具有无可比拟的检测速度、特异性和灵敏度,已成为实验室诊断的新标准。
其中,环介导等温扩增法具有检测灵敏度高、结果判断直观,且不需要荧光定量PCR仪等价格昂贵的设备等优点,具有广泛应用前景。
环介导等温扩增技术(Loop-mediated isothermal amplification, LAMP)是一种新型等温核酸扩增技术,具有快速、简便、经济、灵敏等优点,目前已被广泛应用于核酸快速检测领域。LAMP的原理是针对靶基因上6个区域设计2对引物(FIP[F1c+F2]、BIP[B2+B1c]、F3、B3),在链置换型DNA聚合酶的作用下,于等温条件在短时间内(15~90min)进行核酸扩增。
在反应液中添加荧光物质SYBR GREEN,利用恒温扩增仪检测荧光曲线,有荧光曲线表示待测样品中存在百日咳杆菌(阳性),无扩增曲线表示待测样品中无百日咳杆菌(阴性)。与传统PCR相比,LAMP具有操作简便、灵敏度高、特异性强、结果判定简单、成本低廉等特点。LAMP检测灵敏度至少比普通PCR 高出2个数量级。此外,等温扩增仅需一个水浴锅或恒温装置,对设备的要求简单,其操作过程耗时较短,可在1小时内完成。通过SYBR GREEN等荧光染料对PCR扩增产物的显色,LAMP反应结果的检测可通过等温扩增仪进行可视化呈现,是一种高效、简便、快捷、高通量的检测方法。
因此,开发一种针对百日咳杆菌的环介导等温扩增试剂盒具有重要意义。
发明内容
本发明的目的在于:提供一种用于百日咳杆菌核酸检测的方法;另一目的在于提供一种用于该方法的试剂盒。
1. 百日咳杆菌的LAMP检测专用引物
根据百日咳杆菌基因组特异性保守序列,应用在线引物设计软件Primer ExplorerV5,上传靶序列后,即可初步得到多组引物序列。
根据LAMP引物设计的关键因素,主要包括引物末端的稳定性、GC含量、引物间的距离和二级结构对其进行筛选,最终得到的LAMP引物。具体来说,为了在反应中能使F1c和B1c更加容易弯转,可以形成双茎环结构,引物F1c和B1c要高于其他几条引物的Tm值5℃左右。为提高核苷酸越与模板退火结合效率,每条引物最末端的六个碱基自由能⊿G值≤-4Kcal/mol,F3/B3,F2/B2的3’末端⊿G值≤-4Kcal/mol,F1c和B1c的5’端的⊿G值≤-4Kcal/mol。对于引物的GC含量设定范围在40%~60%之间。对于引物之间的距离,从F2的5’端到B2的5’端应在120~180bp之间,从F2的5’端到F1c的3’端也就是茎环段在40~60bp之间,从F2的5’端到F3的3’端在0~20bp之间。最后要特别注意引物之间不能形成二级结构。通过以上设计原则筛选即得到最终引物如下。
F3: 5’-AGAGCGAATATCTGGCACAC-3’;
B3: 5’-CGCTATGCGCACCAATGTG-3’;
FIP:
5’-TCTCGCCGGTGATGCCGTTGCATTCCGCCCGAAAACATCC-3’;
BIP:
5’-ATTCCAACGCTCGCTACGTCAGCGACGCTACGGACCTTCG-3’。
2. 百日咳杆菌的LAMP检测方法
本发明所提供的百日咳杆菌的LAMP检测方法,主要包括以下步骤:
[1]核酸提取:使用上海复星长征医学科学有限公司生产的磁珠法核酸提取试剂(核酸提取及纯化试剂)对待测样本进行核酸提取。
[2]LAMP扩增
以上述提取的待测物核酸为模板,在专用引物的介导下进行扩增。其中,LAMP反应体系(20 μl)包括:待测物的基因组DNA 5μl,20mM Tris·HCl (pH8.8),10mM(NH4)2SO4,50mMKCl,2mM MgSO4,0.1% Tween20,1M Betaine,0.4mM dNTP each,8U Bst DNA polymerase,SYBR GREEN(1×DMSO PCR级),0.2 μM F3,0.2 μM B3,0.8 μM FIP和0.8 μM BIP。LAMP扩增条件可设定为58~68℃恒温反应15~60min,优选为63℃恒温反应30min。
[3]结果判定
利用恒温扩增仪检测荧光曲线,有荧光曲线表示待测样品中存在百日咳杆菌(阳性),无扩增曲线表示待测样品中无百日咳杆菌(阴性)。
3. 百日咳杆菌的LAMP检测试剂盒
本发明所提供的百日咳杆菌的LAMP检测试剂盒,包含有上述LAMP检测的专用引物、主要试剂和反应参数,本发明具有以下优点:
[1]高特异性
4条引物对靶序列的6个特异区域的识别保证了LAMP扩增的高度特异性,即LAMP能够从相差仅一个核苷酸的基因标本中寻找出相应的靶序列进行扩增;
[2]高效扩增
灵敏度比普通PCR高约100倍;
[3]操作简便
只需将待检样品(靶核酸)和检测试剂置于约63℃恒温扩增仪中反应30min左右即可判断结果;
[4]结果直观
利用恒温扩增仪检测荧光曲线观察反应结果。本发明可以在等温条件下简便快速(63℃恒温反应30min)、高效特异地检测到百日咳杆菌。该法不需要复杂仪器,为百日咳杆菌的检测提供了一个新的技术平台,尤其适用于人群筛查,具有广阔的市场前景和较大的经济、社会效益,适于大范围推广应用。
具体实施方式
现以本发明技术方案为前提,列举出详细的实施方式和具体的操作过程,但本发明的保护范围不限于下述的实施例子。下述实施例中所用方法如无特别说明均为常规方法。
实施例1、用于对百日咳杆菌进行LAMP检测的引物设计
利用NCBI数据库检索获得百日咳杆菌基因组特异性保守序列,应用在线引物设计软件PrimerExplorer V5,上传靶序列后,即可初步得到多组引物序列。根据LAMP引物设计的关键因素,主要包括引物末端的稳定性、GC含量、引物间的距离和二级结构对其进行筛选,最终得到的LAMP引物。
实施例2、用于百日咳杆菌进行LAMP检测方法的建立
用实施例1获得的用于对百日咳杆菌进行LAMP检测的引物对鼻咽拭子样本核酸提取液进行LAMP检测,具体操作步骤如下:
[1]反应体系
使用上海复星长征医学科学有限公司生产的磁珠法核酸提取试剂(核酸提取及纯化试剂)对待测样本进行核酸提取,将提取产物作为模板,在实施例1获得的LAMP专用引物的引导下进行等温扩增。其中,LAMP反应体系(20 μl)包括:待测物的基因组DNA 3μL,20mMTris·HCl (pH8.8),10mM(NH4)2SO4,50mM KCl,2mM MgSO4,0.1% Tween20,1M Betaine,0.4mM dNTP each,8U Bst DNA polymerase,SYBR GREEN(1×DMSO PCR级),0.2μM F3,0.2μM B3,0.8 μM FIP和0.8μM BIP。
[2]结果判定
利用恒温扩增仪检测荧光曲线,有荧光曲线表示待测样品中存在百日咳杆菌(阳性),无扩增曲线表示待测样品中无百日咳杆菌(阴性)。
实施例3、制备百日咳杆菌的LAMP检测试剂盒
将LAMP反应发生混合物即LAMP反应引物(4μM F3和B3;16μM FIP和BIP)、LAMP反应酶(8U/μL Bst DNA polymerase)、反应缓冲液(40mM Tris·HCl, pH8.8;20mM (NH4)2SO4;100mM KCl;4mM MgSO4;0.2% Tween20;2M Betaine;0.8mM dNTP each、SYBR GREEN(2×DMSO PCR级))和阳性对照(含有百日咳杆菌基因组特异性保守序列的质粒稀释液)共同包装,得到百日咳杆菌的LAMP检测试剂盒。
Claims (4)
1.一种用于百日咳杆菌的LAMP检测方法和反应体系。
2.一种百日咳杆菌的LAMP检测方法,主要包括以下步骤:以待测物的基因组DNA为模板,在权利要求1所述专用引物的引导下进行LAMP扩增,通过在反应液中添加SYBR GREEN,利用恒温扩增仪检测荧光曲线,有荧光曲线表示待测样品中存在百日咳杆菌、结果为阳性,无扩增曲线表示待测样品中无百日咳杆菌、结果为阴性。
3.根据权利要求2所述的检测方法,其特征在于:使用磁珠法对待测样本进行核酸提取;LAMP反应体系包括:待测物的基因组DNA 3μL,20mM Tris·HCl (pH8.8),10mM(NH4)2SO4,50mM KCl,2mM MgSO4,0.1% Tween20,1M Betaine,0.4mM dNTP each,8U Bst DNApolymerase,SYBR GREEN(1×DMSO PCR级),0.2μM F3,0.2μM B3,0.8μM FIP和0.8μM BIP。
4.根据权利要求2所述的检测方法,其特征在于LAMP扩增条件为:反应管置于58~68℃恒温反应15~60min,优选为63℃恒温反应30min。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811643101.5A CN111378768A (zh) | 2018-12-29 | 2018-12-29 | 一种检测百日咳杆菌的试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811643101.5A CN111378768A (zh) | 2018-12-29 | 2018-12-29 | 一种检测百日咳杆菌的试剂盒 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111378768A true CN111378768A (zh) | 2020-07-07 |
Family
ID=71220991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811643101.5A Pending CN111378768A (zh) | 2018-12-29 | 2018-12-29 | 一种检测百日咳杆菌的试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111378768A (zh) |
-
2018
- 2018-12-29 CN CN201811643101.5A patent/CN111378768A/zh active Pending
Non-Patent Citations (2)
Title |
---|
WEI LIU等: "Survey and rapid detection of Bordetella pertussisin clinical samples targeting the BP485 in China" * |
马卓娅 等: "双重PCR 快速检测百日咳杆菌" * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111073989B (zh) | 志贺氏菌核酸快速恒温检测方法及应用 | |
CA2506574A1 (en) | One step real-time rt pcr kits for the universal detection of organisms in industrial products | |
CN108060257B (zh) | 一种基于环介导等温扩增技术检测强雄腐霉的引物组合物及其检测方法 | |
CN101899521B (zh) | 一组用于广州管圆线虫环介导等温扩增检测方法中的特异性引物组 | |
CN106191214B (zh) | 一种多色荧光熔解曲线pcr检测方法 | |
CN107686863A (zh) | 环介导等温扩增技术检测三种泌尿生殖道支原体的方法 | |
CN112322705A (zh) | 一种用于多重核酸检测的恒温扩增荧光rma方法 | |
CN112111494B (zh) | 识别铜绿假单胞菌的DNAzymes及筛选检测方法与用途 | |
CN111154900B (zh) | 铜绿假单胞菌特异性新分子靶标及其快速检测方法 | |
CN107338314B (zh) | 闭管可视化鳗源嗜水气单胞菌环介导等温扩增检测方法 | |
CN115747353A (zh) | 一种用于单核细胞增生李斯特菌检测的引物组、试剂、试剂盒及检测方法 | |
CN102010910A (zh) | 基于环介导等温扩增技术的疟原虫属和种的核酸筛查方法 | |
CN117210437A (zh) | 两种基因编辑工具酶鉴定及其在核酸检测中的应用 | |
KR20210127375A (ko) | 자가 프라이머 구조를 가진 헤어핀 프로브를 활용한 등온 증폭기술을 이용한 표적핵산 검출방법 | |
CN110863061A (zh) | 检测金黄色葡萄球菌的特异性lamp引物、试剂盒及方法 | |
CN102329882A (zh) | 三种食源性致病菌多重快速检测法及检测引物组和试剂盒 | |
CN106995842B (zh) | 一种tma熔解曲线法联合焦磷酸测序技术检测临床常见致病细菌的试剂盒及其应用 | |
CN103409499A (zh) | 一种钙黄绿素荧光可视化沙门氏菌lamp检测方法 | |
CN111378769A (zh) | 一种检测肺炎衣原体的试剂盒 | |
CN113481326B (zh) | 一种等温核酸扩增反应试剂、等温核酸扩增方法及其应用 | |
CN111378768A (zh) | 一种检测百日咳杆菌的试剂盒 | |
CN115029345A (zh) | 基于crispr的核酸检测试剂盒及其应用 | |
CN111378724B (zh) | 一种rna放大检测方法及检测试剂盒 | |
CN102533967A (zh) | 霍乱弧菌毒素基因多重实时荧光定量pcr检测试剂盒及方法 | |
CN113337583A (zh) | 一种多重目标核酸的微滴式数字检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200707 |